Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -57.59% is 20% below its 5-year average of -47.86%, around the middle of its 5-year range (-119.66%–-14.79%).
As of the fiscal period ended Tuesday, June 30, 2026. 16.50% above its 12-month average of -68.97%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -57.59%.
RETURN ON INVESTED CAPITAL (ROIC)
-57.59%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-68.97%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-57.16%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-47.86%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+16.50%
CURRENT VS 3Y AVG
-0.75%
CURRENT VS 5Y AVG
-20.32%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-61.56%
vs the sector median at left
PepGen Inc.
Market Cap
$158.74M
Return on Invested Capital (ROIC)
-57.59%
TTM Avg
-68.97%
3Y Avg
-57.16%
5Y Avg
-47.86%
Market Cap
$159.22M
Return on Invested Capital (ROIC)
-143.97%
TTM Avg
-52.39%
3Y Avg
-55.03%
5Y Avg
-91.26%
Market Cap
$159.91M
Return on Invested Capital (ROIC)
-135.38%
TTM Avg
-110.80%
3Y Avg
-91.23%
5Y Avg
-65.73%
Market Cap
$156.68M
Return on Invested Capital (ROIC)
-13.94%
TTM Avg
-16.11%
3Y Avg
-25.11%
5Y Avg
-17.04%
Market Cap
$161.43M
Return on Invested Capital (ROIC)
-38.56%
TTM Avg
-39.74%
3Y Avg
-42.41%
5Y Avg
-37.88%
Market Cap
$162.75M
Return on Invested Capital (ROIC)
-49.08%
TTM Avg
-23.18%
3Y Avg
-21.02%
5Y Avg
-18.22%
Market Cap
$158.14M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-138.87%
3Y Avg
-97.17%
5Y Avg
-81.85%
Market Cap
$152.75M
Return on Invested Capital (ROIC)
-22.15%
TTM Avg
-29.24%
3Y Avg
-31.64%
5Y Avg
-30.48%
Market Cap
$165.51M
Return on Invested Capital (ROIC)
4.92%
TTM Avg
-1.65%
3Y Avg
-7.20%
5Y Avg
-5.46%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PepGen Inc. (PEPG) | $158.74M | -57.59% | -68.97% | -57.16% | -47.86% |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | -143.97% | -52.39% | -55.03% | -91.26% |
| Coherus Oncology, Inc. (CHRS)vs › | $159.91M | -135.38% | -110.80% | -91.23% | -65.73% |
| Inogen, Inc. (INGN)vs › | $156.68M | -13.94% | -16.11% | -25.11% | -17.04% |
| Minerva Neurosciences, Inc. (NERV)vs › | $161.43M | -38.56% | -39.74% | -42.41% | -37.88% |
| Quanterix Corporation (QTRX)vs › | $162.75M | -49.08% | -23.18% | -21.02% | -18.22% |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $158.14M | N/A | -138.87% | -97.17% | -81.85% |
| Neuronetics, Inc. (STIM)vs › | $152.75M | -22.15% | -29.24% | -31.64% | -30.48% |
| OptimizeRx Corp. (OPRX)vs › | $165.51M | 4.92% | -1.65% | -7.20% | -5.46% |
| Nkarta, Inc. (NKTX)vs › | $165.63M | -42.11% | -29.16% | -30.37% | -28.38% |
ROIC
-57.6%
ROE
-60.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -57.59% |
| 2026-03-31 | -55.14% |
| 2025-12-31 | -58.05% |
| 2025-09-30 | -54.41% |
| 2025-06-30 | -119.66% |
| 2025-03-31 | -102.15% |
| 2024-12-31 | -72.84% |
| 2024-09-30 | -61.40% |
| 2024-06-30 | -55.90% |
| 2024-03-31 | -44.21% |
| 2023-12-31 | -67.53% |
| 2023-09-30 | -56.64% |
| 2023-06-30 | -45.03% |
| 2023-03-31 | -39.58% |
| 2022-12-31 | -34.39% |
| 2022-09-30 | -30.22% |
| 2022-06-30 | -22.27% |
| 2022-03-31 | -29.69% |
| 2021-12-31 | -20.33% |
| 2021-09-30 | -14.79% |
| 2021-06-30 | -89.34% |
